QIASCREEN Trademark

Trademark Overview

On Friday, May 17, 2019, a trademark application was filed for QIASCREEN with the United States Patent and Trademark Office. The USPTO has given the QIASCREEN trademark a serial number of 79263897. The federal status of this trademark filing is REGISTERED as of Tuesday, March 3, 2020. This trademark is owned by Qiagen GmbH. The QIASCREEN trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic test kits consisting primarily of nucleic acid sequences or molecules, buffers, reagents, and assays for use in disease testing; medical diagnostic reagents; clinical medical reagents; nucleic acid sequences and chemical reagents for medical purposes
qiascreen

General Information

Serial Number79263897
Word MarkQIASCREEN
Filing DateFriday, May 17, 2019
Status700 - REGISTERED
Status DateTuesday, March 3, 2020
Registration Number5999312
Registration DateTuesday, March 3, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements

Goods and ServicesDiagnostic test kits consisting primarily of nucleic acid sequences or molecules, buffers, reagents, and assays for use in disease testing; medical diagnostic reagents; clinical medical reagents; nucleic acid sequences and chemical reagents for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQiagen GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameQiagen GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameQiagen GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Saturday, August 3, 2019ASSIGNED TO EXAMINER
Thursday, July 25, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, July 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 3, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, August 7, 2019NON-FINAL ACTION WRITTEN
Thursday, August 8, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 9, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, August 27, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, August 26, 2019NON-FINAL ACTION WRITTEN
Saturday, September 28, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 30, 2019NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, September 4, 2019NON-FINAL ACTION WRITTEN
Thursday, September 5, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, September 28, 2019REFUSAL PROCESSED BY MPU
Saturday, October 19, 2019REFUSAL PROCESSED BY IB
Wednesday, October 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2019ASSIGNED TO LIE
Thursday, October 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, June 3, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, July 9, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 9, 2020FINAL DISPOSITION PROCESSED
Friday, July 31, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, June 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 3, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 2, 2022NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

qiascreen reagents medical sequences diagnostic acid nucleic purposes testing chemical clinical